Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Clinical trial NCT02428192 · COMPLETED
Trial details
- NCT number
- NCT02428192
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-19
- Primary completion
- 2018-09-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.